Clinical trial
Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant…
NCT00400322 · Karolinska Institutet, Other · Completed
Key facts
| NCT number | NCT00400322 |
|---|---|
| Title | Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection |
| Official title | A Randomized Double Blind Controlled Proof of Concept Study of the Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma With Successful Surgical Resection of at Least 90 % of the Initial Tumor and CMV Infection Demonstrated Histologically and… |
| Lead sponsor | Karolinska Institutet, Other |
| Collaborators | Karolinska University Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme, Cytomegalovirus Infection |
| Intervention type | Drug, Other |
| Interventions | Valganciclovir (Valcyte), Placebo |
| Enrollment | 42 |
| Start date | Aug 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Nov 16, 2006 |
| Last update posted | Mar 1, 2021 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: